Aminoglycoside
Back to Test Catalogue
Amikacin – Random, Serum
Test ID: AMIKR
Test
Aliases/Synonyms
Method
Kinetic Interaction of Microparticles in Solution (KIMS) Immunoassay
Platform
Roche cobas 6000
Report Includes
Amikacin
Specimens
Avoid gel separator tubes; Serum
Test Location
St. Michael's Hospital, 30 Bond Street, Toronto ON M5B 1W8
Test Version
2-Mar-2023
Specimen
Specimens
Avoid gel separator tubes; Serum
Collection Containers
Red top (no additive)
Sample Volume
1 mL
Minimum Volume
0.5 mL
Collection & Handling
Collection Instructions
Avoid gel-separator tubes.
For traditional dosing, collect sample 30 minutes after end of dose infusion. Wait until the third dose before collecting samples for therapeutic monitoring.
For extended dosing, after the third dose collect a sample 8 – 12 hours after end of dose infusion. Record the exact time of sampling and use nomogram for dosage adjustment if necessary.
Handling Information
Separate samples from cells as soon as possible. Repeated freezing and thawing of samples should be avoided
Stability
| Ambient | 4 hours |
|---|---|
| Refrigerated | 7 days |
| Frozen | 14 days |
Rejection Criteria
| Specimen | Gel separator tube |
|---|---|
| Hemolysis | Present |
| Icterus | Present |
Test Version
2-Mar-2023
Performance / Interpretation
Method
Kinetic Interaction of Microparticles in Solution (KIMS) Immunoassay
Platform
Roche cobas 6000
Turnaround Time
1 Day
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Amikacin - Random | mg/L |
|
||
|
Refer to guidelines for Aminoglycoside dosing at your institution.
|
||||
Test Location
St. Michael's Hospital, 30 Bond Street, Toronto ON M5B 1W8
Test Version
2-Mar-2023
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| AMIKR | 5850Amikacin | mg/L |
Test Version
2-Mar-2023